Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India

BACKGROUND: Plerixafor is used for patients at risk of Stem cell mobilization failure based on clinical factors or low peripheral blood CD34 count. It is also added upfront to any mobilization irrespective of risk factor, but the cost-effectiveness of the approach is an issue. Data on plerixafor in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Soumya Das, Smita Kayal, Biswajit Dubashi, Abhishekh Basavarajegowda, Nanda Kishore Pasupala, Rajendra Kulkarni, Krishnappa Dhanraju, Chinmaya Kumar Pani
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2022-01-01
coleção:	Asian Journal of Transfusion Science
Assuntos:	autologous hematopoietic stem cell transplantation india plerixafor
Acesso em linha:	http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=1;spage=7;epage=14;aulast=Das
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!